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Abstract
Background: Transcription factors function by binding different classes of regulatory elements. The Encyclopedia
of DNA Elements (ENCODE) project has recently produced binding data for more than 100 transcription factors
from about 500 ChIP-seq experiments in multiple cell types. While this large amount of data creates a valuable
resource, it is nonetheless overwhelmingly complex and simultaneously incomplete since it covers only a small
fraction of all human transcription factors.
Results: As part of the consortium effort in providing a concise abstraction of the data for facilitating various types
of downstream analyses, we constructed statistical models that capture the genomic features of three paired types
of regions by machine-learning methods: firstly, regions with active or inactive binding; secondly, those with
extremely high or low degrees of co-binding, termed HOT and LOT regions; and finally, regulatory modules
proximal or distal to genes. From the distal regulatory modules, we developed computational pipelines to identify
potential enhancers, many of which were validated experimentally. We further associated the predicted enhancers
with potential target transcripts and the transcription factors involved. For HOT regions, we found a significant
fraction of transcription factor binding without clear sequence motifs and showed that this observation could be
related to strong DNA accessibility of these regions.
Conclusions: Overall, the three pairs of regions exhibit intricate differences in chromosomal locations, chromatin
features, factors that bind them, and cell-type specificity. Our machine learning approach enables us to identify
features potentially general to all transcription factors, including those not included in the data.
Background
Transcription factors (TFs) are proteins that bind speci-
fic DNA elements and regulate gene transcription.
There are approximately 1,700 to 1,900 TFs in human,
including about 1,400 manually curated sequence-speci-
fic TFs [1]. They bind different types of DNA elements,
including promoters, enhancers, silencers, insulators and
locus control regions [2]. While promoters are close to
transcription start sites (TSSs), the other types of ele-
ments could be far away from the genes that they regu-
late, and there are no simple rules known to define their
exact locations. For instance, enhancers can be as far as
one mega base pairs (1 Mbp) from the target gene in
eukaryotes [3], and can be both upstream and down-
stream of the promoter of the target gene [4].
One important step towards a thorough understanding
of transcriptional regulation is to catalog all regulatory
elements in a genome. There are databases for regula-
tory elements with experimental data [5-7]. The comple-
teness of these databases has been limited by a small
number of validation experiments performed relative to
the expected number of regulatory elements, and a
small amount of TF binding data available relative to
the total number of TFs. There are also a lot of compu-
tational methods for predicting cis-regulatory modules,
many of which are based on evolutionary conservation
and binding motif densities and distributions [8,9]. Since
these features are static information that does not take
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into account the dynamic environment of DNA, such as
DNA methylation, nucleosome occupancy and histone
modifications, these predictions usually have high false
positive rates.
To systematically identify TF binding sites on a large
scale, high-throughput methods such as chromatin
immunoprecipitation followed by sequencing (ChIP-seq)
[10,11] have been invented. With a goal to identify all
functional elements in the human genome, the Encyclo-
pedia of DNA Elements (ENCODE) project [12] has
used high-throughput methods to produce a large
amount of experimental data for studying TF binding
sites. In the pilot phase, which aimed at studying 44
regions that sum up to about 1% of the human genome
[13], the binding sites of 18 sequence-specific TFs and
components of the general transcription machinery were
identified using chromatin immunoprecipitation fol-
lowed by microarray (ChIP-chip) [14,15], paired-end tag
sequencing (ChIP-PET) [16], and sequence tag analysis
of genomic enrichment (STAGE) [17]. Analysis of a sub-
set of these data revealed non-uniform distribution of
TF binding sites in the surveyed regions, statistical asso-
ciation of the binding sties with both TSSs and tran-
scription end sites of known genes, and clustering of
binding sites of different TFs [18].
With the success of the pilot phase, ENCODE has
entered its production phase since 2007 to study DNA
elements in the whole human genome. Both the scale
and variety of experiments have been greatly increased
[19,20]. In terms of protein-DNA binding, many ChIP-
seq experiments have been performed to identify the
binding sites of sequence-specific TFs, general TFs, and
chromatin-related factors, which we will call transcrip-
tion-related factors (TRFs) in general. About 500 ChIP-
seq datasets have been produced, involving more than
100 different TRFs in more than 70 cell lines [20].
There are also matched expression data and chromatin
features, such as histone modifications from ChIP-seq
experiments, and DNA accessibility from DNase I
hypersensitivity analysis [21,22] and formaldehyde-
assisted isolation of regulatory elements (FAIRE) [23],
making the dataset a valuable resource for studying
transcriptional regulation.
Having this large amount of data available notwith-
standing, it is still non-trivial to identify all regulatory
elements and provide useful annotations for them due
to two major reasons. First, the fraction of TRFs
included in the experiments is still small compared to
the total number of TRFs in human. For instance, if a
regulatory element is only bound by TRFs not covered
by these experiments, it cannot be identified simply by
cataloging all the observed TRF binding sites. Instead, it
is necessary to model each type of regulatory element
by some general features that are available for the whole
genome, and use these features to extend the search of
the elements to regions not covered by the experiments.
Second, the overwhelming amount of data makes it
difficult to extract useful information. Processing hun-
dreds of genome-scale data files requires a lot of com-
putational resources even for simple analysis tasks, not
to mention the complexity in cross-referencing other
types of related data, such as gene expression and his-
tone modifications. Statistical significance of observa-
tions is also difficult to evaluate due to non-uniform
distribution of genomic elements and complex depen-
dency structures within a single dataset and between dif-
ferent datasets.
Here we report our work in using statistical methods
to learn general properties of different types of genomic
regions defined by TRF binding. We also describe the
application of the learned models in locating all occur-
rences of these types of regions in the whole human
genome in different cell types, including locations with
no direct experimental binding data. Our main goal is
to provide a concise and accessible summary of the
large amount of data in the form of several types of
regions with clear interpretations, to facilitate various
kinds of downstream analyses.
Specifically, we report our identification of six differ-
ent types of genomic regions that can be grouped into
three pairs: regions with active/inactive binding; regula-
tory modules proximal to promoters/distal to genes; and
regions with extremely high/low degrees of co-occur-
rence of binding by factors that do not usually co-
associate. We discuss the chromosomal locations of
these regions, their cell-type specificity, chromatin fea-
tures and different sets of TRFs that bind them, and
show that a variety of properties of our called regions
are in strong agreement with prior knowledge of TRF
binding.
To further explore functional aspects of the identified
regions, we report our work in predicting enhancers
from the distal regulatory modules and validating their
activities by reporter assays. We also link distal regula-
tory modules to potential target genes and identify the
TRFs involved. Finally, we suggest a potential relation-
ship between non-sequence-specific TRF binding and
DNase hypersensitivity at regions with high co-occur-
rence of TRF binding. All these whole-genome analyses
would have been difficult to carry out without the large
cohort of data produced by ENCODE.
Related ideas for identifying different types of regions
in the whole genome have been proposed, both by
groups within ENCODE and by other groups. One
approach is to use one or a few previously known fea-
tures to define particular region types, such as using
DNase I hypersensitivity and some specific histone
marks in identifying enhancers. In comparison, our
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approach identifies feature patterns directly from data
using a machine learning framework, which has the
potential to discover novel features for specific region
types. Another related idea is to segment the genome
in an ‘unsupervised’ fashion, that is, to group regions
based on observed data alone without any predefined
region types. This approach is most suitable for
exploring new region types. A big challenge of this
approach is to interpret the resulting segments. In the
current work we focus on the six types of regions
described, and take on a ‘supervised’ approach when-
ever possible, that is, to learn general properties of a
region type using known examples. When there are
sufficient examples, the supervised approach is usually
preferred in identifying members of well-defined
classes.
Results
Identification of six types of genomic regions based on
TRF binding data
We selected five ENCODE cell lines that have the lar-
gest numbers of TRFs with binding sites assayed by
ChIP-seq (Table S1 in Additional file 1). In total, 117
TRFs are included in the ENCODE datasets from the
five cell lines. The data files were processed by the
ENCODE pipeline [24], which includes signal quality
and reproducibility tests by comparing data from repli-
cate experiments, a uniformly applied procedure for
calling binding peaks (using PeakSeq [25] for our
selected subset of data), and the removal of problematic
regions due to issues such as repeats and sequences
with low mappability.
For each of the five cell lines, we used the cell-line-
specific TRF binding data to learn patterns in chromatin
features and gene expression levels using machine learn-
ing methods. We then used the learned models to
define six different types of genomic regions that form
three pairs: 1) binding active regions (BARs) and bind-
ing inactive regions (BIRs); 2) promoter-proximal regu-
latory modules (PRMs) and gene-distal regulatory
modules (DRMs); and 3) high occupancy of TRF (HOT)
regions, and low occupancy of TRF (LOT) regions (Fig-
ure 1). In each pair, the two region types are mutually
exclusive. On the other hand, region types from differ-
ent pairs may overlap. For instance, DRMs are subsets
of BARs, while some HOT regions overlap with PRMs
and DRMs. Each of the six types of regions, however,
exhibits some unique properties and we will discuss the
six types separately. With the use of cell-line-specific
data, we aimed at identifying regions that reflect the
internal states of the particular cell types. For PRMs and
DRMs, for example, our goal was to identify modules
that have active regulatory roles in the particular cell
line from which they were called, instead of modules
that are only potentially active in some unknown cell
types [26].
Binding active regions and binding inactive regions
We first identified broad genomic regions that TRFs
tend to bind, which we call binding active regions
(BARs). One simple way to define BARs is to collect all
regions covered by the binding peaks of the TRFs in our
dataset, which are regions with the strongest binding
signals compared to the local genomic backgrounds.
However, while we are using one of the largest sets of
ChIP-seq data currently available, it contains only a
small portion of the estimated 1,700 to 1,900 human
TFs [1]. We therefore took the regions covered by the
TRF binding peaks as examples to learn a statistical
model based on the observed chromatin features of
these regions for each cell line using data produced by
ENCODE (Materials and methods). We then applied the
model to score all regions in the whole human genome.
Cross-validation results show that our learned models
can separate regions covered by TRF binding peaks
from other random regions well (Figures S1 and Figure
S2 in Additional file 2). Since some of the selected ran-
dom regions may actually be bound by TRFs not in our
dataset, we do not expect 100% accuracy, and the
observed accuracy values are sufficiently high to indicate
that our models have captured some general chromatin
properties of regions with active binding. We then
defined a cutoff threshold to define BARs for each cell
line as regions with a score higher than it (Materials
and methods).
To contrast with BARs, we also defined BIRs as
regions that have low BAR scores and are not covered
by any binding peaks of the TRFs in our dataset.
Promoter-proximal regulatory modules and gene-distal
regulatory modules
Among the TRF binding sites, one subset of particular
interest comprises those close to the TSSs of active
genes, as they are likely actively involved in the regula-
tion of these genes in the corresponding cell lines.
Depending on the distance from a TSS, these regions
may contain core promoters and proximal promoter ele-
ments [2]. We call these regions promoter-proximal reg-
ulatory modules (PRMs) in general. To define PRMs,
instead of using an arbitrary distance threshold from
TSSs, we determined distance cutoffs according to chro-
matin feature patterns using a machine learning frame-
work. Specifically, for each cell line, we took TSSs of
genes expressed in the cell line as positive examples,
and random non-TRF binding sites and distal TRF bind-
ing sites as negative examples (Materials and methods).
Expression of TSSs was determined by ENCODE data
from cap-analysis of gene expression (CAGE) [27],
paired-end diTag (PET) [28], and RNA sequencing
(RNA-seq) [29,30]. Based on the examples, a
Yip et al. Genome Biology 2012, 13:R48
http://genomebiology.com/2012/13/9/R48
Page 3 of 22
discriminative model was learned using chromatin fea-
tures and TRF binding data of the cell line as explana-
tory variables. The resulting models separated positive
and negative examples well in all cell lines (Figures S3
and S4 in Additional file 2). Finally we used the learned
models to give PRM scores to all regions in the whole
genome. Since in this case we have a relatively complete
set of positive examples from annotated genes, we used
Figure 1 Overview of the pipeline for identifying the six types of regions for one cell line. The left side shows the input data involved.
The right side shows how these datasets were used to identify the regions. The same pipeline was applied to five different cell lines. See
Materials and methods for details. The color scheme for the six regions is used in all figures and supplementary figures of the paper. CAGE, cap-
analysis of gene expression; exp., experiment.
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a more stringent threshold to call PRMs (Materials and
methods).
In contrast to PRMs, there are also regulatory mod-
ules that are more distal to promoters. For example,
enhancers are frequently thousands of bases pairs
upstream or downstream of a promoter, and they can
be within an intron of a gene [2]. To study properties
unique to this type of DNA element, we focused on
BARs at least 10 kbp from any annotated coding and
non-coding transcript (Materials and methods) and
removed from this list any identified PRMs, to eliminate
properties superimposed from annotated and potentially
unannotated genes.
High occupancy of TRFs and low occupancy of TRFs regions
In addition to binding potential and relative distance
from genic features, TRF binding regions can also be
classified by the likelihood of co-occurrence of TRF
binding sites. In separate studies we have observed
widespread co-occurrence of binding sites of different
TRFs [20,31]. An extreme case is the binding of many
TRFs at the same narrow regions on the scale of around
a hundred base pairs. While it is physically impossible
to have many TRFs binding a small site at this scale at
the same time in a single cell, different TRFs can simul-
taneously bind to the same site in a population of cells
and be detected by a single ChIP-seq experiment. We
were particularly interested in regions bound by many
TRFs that do not frequently co-associate globally in the
whole genome. We call this kind of event region-specific
TRF co-occurrence. For instance, since members of the
c-Jun and c-Fos families dimerize to form the AP-1
transcription factor [32], their binding sites co-occur
globally [20] and this kind of co-occurrence is not
regarded as region-specific TRF co-occurrence.
We derived a method to compute the degree of
region-specific co-occurrence of TRF binding sites,
which takes into account both the binding signals and
global co-occurrence of TRFs (Materials and methods).
Basically, binding peaks with stronger, more reliable
binding signals are weighted more, while sets of TRFs
that frequently co-occur in the whole genome are
group-wise down-weighted.
We found that the degree of region-specific TRF co-
occurrence forms a smooth distribution with no obvious
peaks except at around zero due to regions with no TRF
binding (Figure S5 in Additional file 2). We extracted
the most extreme cases and defined HOT regions and
LOT regions as the regions with the highest and lowest
(but non-zero) degrees, respectively (Materials and
methods). Genome-wide analyses of HOT regions have
been performed before in Caenorhabditis elegans [33]
and Drosophila [34]. In the current work we developed
an improved computational method to study these
regions at the genome scale in human.
Genomic locations of the six types of regions
The six types of regions identified by our computational
methods occupy from about 15.5 Mbp (PRMs in H1-
hESC, equivalent to 0.50% of the human genome) to 1.39
Gbp (BIRs in GM12878, equivalent to 45% of the human
genome) in the different cell lines (Table 1). At a global
scale, their locations are highly non-uniform and inter-
related (Figures 2a; Figure S6 in Additional file 2; visuali-
zation by Circos [35]). BARs are correlated with gene
density (Figure 2b). PRMs and DRMs are, by definition,
distributed according to gene locations. For HOT
regions, about 70 to 80% of them are within 10 kbp of
annotated coding and non-coding genes, while the
remainder are at intergenic regions (Table 1). In contrast,
only about half of the LOT regions are close to or overlap
genes, and the other half are within intergenic regions.
Figure 2c shows the relative locations of the six types
of regions in an example area at the beginning of the q-
arm of chromosome 22 in K562 (visualization by IGV
[36]). There are large segments of DNA covered by BIRs
with low gene activities as measured by RNA-seq. BARs
are, in general, distributed according to gene locations,
but there are two major subtypes. One subtype corre-
sponds to broad areas with extensive TRF binding and
co-binding, as indicated by continuous BAR and HOT
regions, respectively (Figure 2c, box i). The other sub-
type involves regions with interspersed active and inac-
tive TRF binding, where only a small fraction of the
PRMs and DRMs intersect with HOT regions (Figure
2c, box ii). As discussed below, the former likely corre-
sponds to general open chromatin regions with potential
‘motifless’ binding, while the latter involves more
sequence-specific binding.
In general, each of the six types of regions shows a
high level of consistency across different cell lines (Fig-
ure 3a; Figure S7 in Additional file 2), despite the fact
that the regions in different cell lines were called inde-
pendently using datasets from different sets of TRFs.
For example, while no constraints were placed as to
where the BARs should be called in the whole genome,
their resulting genomic distributions in the different cell
lines are highly similar (Figure S7A in Additional file 2).
Amid the general consistency, some subtle cell-type-
specific patterns are also observed. At the genome scale,
H1-hESC is found to differ most from the other cell
lines by having much lower average densities of all
regions except BIRs, which highlights the drastic differ-
ence between embryonic stem cells and differentiated
cells. Among the different chromosomes, there is a
higher density of BARs on chromosome 19 in H1-hESC,
many of which are DRMs (Figure 3a, box I; Figure S7A
in Additional file 2). The high density of BARs is consis-
tent with both the intrinsic high gene density of chro-
mosome 19 [37], and the highest over-representation of
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genes expressed on this chromosome in human embryo-
nic stem cells, as previously observed [38].
Some local regions also exhibit cell line specificity. For
example, the p-arm of chromosome 5 has a much
higher density of DRMs in HeLa-S3 than the other cell
lines (Figure 3a, box ii). This region also has a high
degree of region-specific co-occurrence of TRF binding
(Figure S7E in Additional file 2), which is not found in
the other four cell lines. There were previous reports
that HeLa cells contain three to five copies of isochro-
mosome 5p [39], which may have caused stronger bind-
ing and open chromatin signals.
We then systematically computed the overlap of each
type of region in the different cell lines. Overall, BIRs
show the highest level of consistency, with 18% of all
BIR bins identified from the different cell lines com-
monly shared by all five cell lines, and only 29% unique
to one particular cell line (Figure 3b). In contrast, active
regions show higher levels of cell-line specificity. For
example, 76% of the indentified HOT regions are speci-
fic to only one cell line, which means, on average, each
cell line contributes about 15% unique regions to the
whole set of HOT regions.
We also examined all combinations of the five cell
lines, and found that Hep-G2 missed a substantial set of
BIRs present in the other cell lines (Figure 3c, box i),
which can also be observed from a density plot (Figure
S7B in Additional file 2). In general, no two cell lines
appear to be particularly more similar to each other than
to other cell lines in terms of the six types of regions.
Chromatin features of the six types of regions
We then studied various chromatin features of the six
types of regions, including open chromatin signatures
and histone modifications. The set of histone modifica-
tions from the ENCODE experiments consists of both
active (for example, histone 3 lysine 4 tri-methylation
(H3K4me3)) and repressive (for example, H3K9me3)
marks, as well as marks that are usually found at pro-
moters (for example, H3K4me3), gene bodies (for exam-
ple, H3K36me3) and distal elements (for example,
H3K4me1) (Table S2 in Additional file 1) [40].
For each combination of cell line, region type and
chromatin feature, we collected the signal values of the
feature at all regions of that type in the cell line to form
a distribution (Materials and methods). We then com-
pared these distributions of different types of regions.
The full set of distributions is shown in Figure S8 in
Additional file 2 using box-and-whisker plots (visualiza-
tion by JFreeChart [41]).
Figure 4 shows some of the characteristic chromatin
features of the different regions. For each type of data, we
have picked a particular dataset from the K562 cell line
for illustration, but the general trends are also observed
in other datasets in K562 and in other cell lines.
BARs, PRMs and DRMs have strong open chromatin
signals (Figure 4a,b), consistent with their expected roles
as active gene regulatory elements [21,23,42]. PRMs have
stronger H3K4me3 signals and DRMs have stronger
H3K4me1 signals (Figure 4c,e), which are expected since
H3K4me3 is a signature of active promoters while
H3K4me1 is an indicator of enhancers [43]. Both PRMs
and DRMs have enriched H3K4me2 signals over the
whole genome, which is also consistent with previous
observations [40]. PRMs have stronger H3K36me3 and
H3K79me2 signals (Figure S8 in Additional file 2) than
DRMs. These histone marks are found in transcribed
regions [44-46], and are thus good features for
Table 1 Total sizes of the six types of genomic regions derived from transcription factor binding data in the five cell
lines
Region type GM12878 H1-hESC HeLa-S3 Hep-G2 K562
Binding active regions (BARs) 109 Mbp (3.5%) 78.8 Mbp (2.6%) 93.6 Mbp (3.0%) 88.8 Mbp (2.9%) 98.7 Mbp (3.2%)
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Numbers in parentheses are the percentages of the whole human genome covered by the regions. Intergenic regions are defined as regions at least 10 kbp
from any level 1 or level 2 gene defined in Gencode version 7.
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distinguishing between regulatory elements that are close
to and those that are far away from transcribed genes.
We notice that histone 3 lysine 27 acetlylation
(H3K27ac), which is expected to be enriched at enhan-
cers [40], has much stronger signals at both PRMs and
DRMs than the genomic background. However, the
enrichment is slightly stronger at PRMs than DRMs. It
is likely caused by a combination of reasons. First, our
DRMs consist of all kinds of distal regulatory elements,
which may include non-enhancers such as insulators
and silencers that do not have strong H3K27ac signals.
Second, some enhancers are within 10 kbp of a gene,
which are not included in the DRM set based on our
current definition. Third, some of our DRMs may be
inactive or poised enhancers, which have weaker
H3K27ac signals [47], although they still have strong
H3K4me1 signals in general. Finally, clear H3K27ac sig-
nals have also been previously reported at promoters in
four of the five cell lines we are considering, in the
ENCODE pilot regions based on ChIP-chip data [48],
which suggests that this histone modification may also
have a functional role at promoters.
One slightly surprising result is that, compared to the
genomic background, PRMs and DRMs are not depleted
of H3K9me3 signals, which were thought to be repres-
sive marks. Previous studies reported the presence of
H3K9me3 at transcribed regions of active genes [49,50].
Our results suggest the possibility that some active regu-
latory elements may have both classical active marks
(such as H3K4me3) and H3K9me3 simultaneously.
When two different amino acid residues (H3K4 and
H3K9) are involved, it is also possible for the same his-
tone protein to have both kinds of marks. Since PRMs
are highly associated with transcribed genes, we
hypothesize that having some strong active marks may
be sufficient to counter the effects of repressive marks.
Both BIRs and LOT regions are depleted of most of
the histone modifications relative to the whole genome.
BIRs are slightly more enriched for open chromatin and
repressive (H3K9me3 and H3K27me3) signals, which
suggest that BIRs are more accessible to TRFs but tran-
scriptional activities are repressed, while LOT regions in
general have low DNA accessibility.
Comparing with the other five types of regions, HOT
regions are characterized by strong enrichment for
almost all kinds of open chromatin and histone modifi-
cation signals. The enrichment over other types of
regions is particularly strong for open chromatin signals,
indicating high accessibility of DNA at these regions.
TRFs that bind the six types of regions
We further studied the TRFs that bind the different
types of regions by examining their binding signals
Figure 2 Distribution of the six types of regions in the genome
in K562. (a) Densities of the regions in the whole genome, defined
as the running fractions of bases covered by the regions. The tracks
are, respectively, from outermost to innermost, the ideogram for the
human karyotype (genome build hg19), Gencode version 7 level 1
and level 2 genes, BARs, BIRs, PRMs, DRMs, HOT regions and LOT
regions. The tracks are scaled separately to show density
fluctuations. The highlighted segment corresponds to the area in
(b). (b) Zoom-in of chromosome 3 to show the correlated
fluctuations of the different types of regions. (c) Locations of the six
types of regions at the beginning of the q-arm of chromosome 22
in K562. Due to the high density of genes, only a subset of the
gene names is shown. Expression values were measured by long
poly-A+ RNA-seq of whole-cell RNA extract. A darker color indicates
a higher average expression level in the local region. Box i marks a
broad area with significant active TF binding and co-binding. Box ii
marks an area with many small interspersed active and inactive TF
binding regions.
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(Materials and methods). The whole set of results is
shown in Figure S8 in Additional file 2. The binding
signals of some selected TRFs in K562 are shown in
Figure 5.
As expected, the binding signal of RNA polymerase II
(POL2RA) is strongly enriched at PRMs compared to
the genomic background, and at DRMs to a lesser
extent. In contrast, the binding signal of RNA polymer-
ase III (POL3RA), which transcribes some non-coding
RNAs, such as rRNAs and tRNAs, is not enriched at
PRMs and only slightly enriched at DRMs.
DRMs have stronger binding signals of CTCF and the
cohesin proteins RAD21 and SMC3 than PRMs, which
in turn have stronger binding signals than the whole
genome in general. The stronger signals at DRMs than
PRMs is consistent with the known role of CTCF in
binding insulators [51,52] and the frequent co-occur-
rence of the binding sites of CTCF and the cohesin
complex [53,54]. On the other hand, the stronger signals
at PRMs than the genomic background suggest that
CTCF also binds some proximal regions, which may
reflect the ability of it to act as a transcriptional insula-
tor, repressor or activator depending on the context of
the binding site [55,56]. A recent study also found that,
contrary to the enhancer blocking model, CTCF may
actually promote communication between functional
regulatory elements by connecting promoters and
enhancers through long-range DNA interactions [57].
EP300, which is found at some enhancers [58], has a
slight enrichment at DRMs. The same trend is also
observed for GATA1 and GATA2 (Figure 5d; Figure S8
in Additional file 2), which were reported to enhance
the expression of some genes [59,60]. In comparison,
some TRFs (such as E2F4) are strongly enriched at
PRMs compared to DRMs, and some (such as USF2)
have almost the same enrichment at PRMs and DRMs.
As defined, HOT regions have strong binding signals
of many TRFs, a lot of which do not usually bind the
same sites. LOT regions, on the other hand, have only
weak binding signals.
In addition to binding signals measured from ChIP-
seq experiments, we also studied binding peaks of the
TRFs called by the ENCODE procedure, which can be
considered as the locations with the strongest binding
signals compared to the local genomic background. For
each TRF binding experiment, we computed the fraction
of peaks within each of the six types of regions and the
intergenic portions of HOT and LOT regions (Figure S9
in Additional file 2). In most cases, most binding peaks
are within BARs. Specifically, considering all five cell
lines, in about half of the experiments more than 90% of
the binding peaks are within BARs. The distribution of
binding peaks between PRMs and DRMs generally
agrees with our observations in the analysis of binding
Figure 3 Distribution of the DRMs in the five different cell lines.
(a) Densities of the regions in the whole genome, defined as the
running fractions of bases covered by the regions. The tracks are,
respectively, from the outermost to the innermost, the ideogram for
the human karyotype (genome build hg19), Gencode version 7 level
1 and level 2 genes, and regions in GM12878, H1-hESC, HeLa-S3,
Hep-G2 and K562. The five innermost tracks are all in the same scale.
Box i shows an area with an exceptionally high density of DRMs on
chromosome 19 in the h1-hESC line. Box ii shows an area with
exceptionally high density of DRMs on chromosome 5 in HeLa-S3
cells. (b) Fraction of bins covered by the six types of regions shared
by different numbers of cell lines. (c) Fraction of bins covered by the
six types of regions shared by the 31 possible combinations of the 5
cell lines. Box i marks the high fraction of BIR bins shared by cell lines
GM12878, H1-hESC, HeLa-S3, and K562.
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signals. In K562, for example, E2F4 has 52% binding
peaks at PRMs and only 11% at DRMs, while GATA2
has the reverse trend, with 14% binding peaks at PRMs
and 26% at DRMs.
Some TRFs preferentially bind intergenic HOT
regions. In K562, for example, 17% of EP300 binding
sites are at intergenic HOT regions, which is likely due
to enhancers in these regions. On the other hand, the
RNA polymerase III protein POLR3G and the TFIIIB
transcription initiation complex subunits BDP1, BRF1
and BRF2 have, respectively, 29%, 24%, 30% and 24% of
their binding sites at intergenic HOT regions, which
may mark promoters of yet unannotated non-coding
genes.
Identification and validation of potential enhancers
To explore potential functional roles of our identified
DRMs, we derived computational methods for
Figure 4 Chromatin features of the six types of regions in K562. (a) DNase I hypersensitivity from the dataset Uw.OpenChrom.K562.Dnase.
Na (compare Figure S8E in Additional file 2). (b) FAIRE signals from the dataset Unc.OpenChrom.K562.Faire.Na. (c) H3K4me1 signals from the
dataset Broad.Histone.K562.H3K4me1.Std. (d) H3K4me2 signals from the dataset Broad.Histone.K562.H3K4me2.Std. (e) H3K4me3 signals from the
dataset Broad.Histone.K562.H3K4me3.Std. (f) H3K9me3 signals from the dataset Broad.Histone.K562.H3k9me3.Std. (g) H3K27ac signals from the
dataset Broad.Histone.K562.H3k27ac.Std. (h) H3K27me3 signals from the dataset Uw.Histone.K562.H3k27me3.Std. (i) H3K36me3 signals from the
dataset Uw.Histone.K562.H3k36me3.Std. Each dataset ID has the format <Data source>.<Experiment type>.<Cell line>.<Open chromatin method/
histone modification/TF>.<Experiment details>. The dot in each box-and-whisker plot is the average value. Some outlier values are not shown.
See Materials and methods for details.
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predicting distal enhancers and tested these predictions
using reporter assays.
First round of validation: human enhancers active in mouse
embryos
We first predicted potential human enhancers that are
active in mouse embryos on embryonic day 11.5. Speci-
fically, from the list of BARs, we selected those that are
far away from TSSs and exons, and scored them based
on both their sequence conservation and the presence
of motifs of TRFs known to be expressed in mouse
embryos (Materials and methods). We then took the top
50 predictions, and randomly chose 6 of them for
experimental validation (Table S3 in Additional file 1).
These six regions were extended according to some
experimental requirements, and tested for enhancer
activities in a mouse assay previously established [61].
These experiments were performed by Dr Len Pennac-
chio’s group, for testing a larger cohort of, in total, 33
potential enhancers identified by several sub-groups of
the ENCODE consortium using different prediction
Figure 5 TRF binding signals of the six types of regions in K562. (a) CTCF signals from the dataset Uta.Tfbs.K562.Ctcf.Na. (b) E2F4 signals
from the datasets Sydh.Tfbs.K562.E2f4.Ucd. (c) EP300 signals from the dataset Sydh.Tfbs.K562.P300f4.Iggrab. (d) GATA1 signals from the dataset
Sydh.Tfbs.K562.Gata1.Ucd. (e) POLR2A signals from the dataset Sydh.Tfbs.K562.Pol2.Std. (f) POLR3G signals from the dataset Sydh.Tfbs.K562.Pol3.
Std. (g) RAD21 signals from the dataset Sydh.Tfbs.K562.Rad21.Std. (h) SMC3 signals from the dataset Sydh.Tfbs.K562.Smc3ab9263.Iggrab. (i) USF2
signals from the dataset Sydh.Tfbs.K562.Usf2.Std. Each dataset ID has the format <Data source>.<Experiment type>.<Cell line>.<Open chromatin
method/histone modification/TF>.<Experiment details>. The dot in each box-and-whisker plot is the average value. Some outlier values are not
shown. See Materials and methods for details.
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methods (Pennacchio and The ENCODE Project Con-
sortium, unpublished data).
Among our 6 tested predictions, 5 (83%) were found
to have enhancer activities in various tissues with good
reproducibility (Table 2; data available at the VISTA
database [6]). Interestingly, most predicted enhancers
were found to be active in tissues related to neurodeve-
lopment, which is likely due to the particular set of
development-related TRFs we considered in our
method.
Second round of validation: General human enhancers in
the whole genome
With the initial success in the first round of small-scale
experimental validations, we set out to take on the more
difficult task of predicting all enhancers in the human
genome. It was part of a larger effort of ENCODE to
predict and experimentally validate various types of
DNA elements, including promoters, enhancers and
insulators. The predictions were made by different
methods and validated by in vivo assays in transgenic
mouse embryos and Medaka fish [20].
In order to identify general enhancers, we modified
our prediction procedure to replace information specific
to the mouse assay, such as the binding motifs of TRFs
expressed in mouse embryos, by some general features
of enhancers, such as signals of the histone modification
H3K4me1. We developed two complementary methods,
and took the intersection of them as our high-confi-
dence predictions (Materials and methods). In total, we
identified 13,539 potential enhancers (full list available
in Additional file 1), among which 50 were randomly
chosen; 20 of them were tested by the mouse assay, and
an independent set of 27 were tested by the Medaka
fish assay (Materials and methods).
The validation results for the mouse and fish assays
are shown in Tables 3 and 4, respectively. In the mouse
experiments, 6 of the 20 (30%) tested sequences showed
enhancer activities in various types of tissues in the
nose, heart, limb and tail. In the fish experiments, 19 of
the 27 (70%) tested sequences showed some enhancer
activities, out of which 15 (56%) had strong activities.
Eleven predictions were tested in both types of assays
(Table 3). In seven cases, enhancer activities were
detected only in the fish experiments, which highlights
the condition specificity of enhancers and the benefits of
combining results of multiple types of experiments.
Our predictions achieved a higher success rate in the
fish assay than a random background set (1/10 = 10%
with weak activities), a set of baseline predictions picked
from repeat-free regions with binding motifs in Transfac
[62] (14/26 = 54% with some activities, out of which 8/
26 = 31% had strong activities), and a computational
method that segments the whole genome into different
classes based on chromatin features (17/29 = 59% with
some activities, out of which 15/29 = 52% had strong
activities) [20].
Comparing the results of the two rounds of experi-
mental validations, while it is hard to draw a definitive
conclusion due to the small number of predictions
tested, the success rate of our predictions in the first
round appears to be higher. This is expected as the pro-
blem settings for the two rounds are very different. In
the first round, we made only a small number of predic-
tions, which correspond to the most confident cases
with the strongest signals. In contrast, in the second
round, we made a much larger number of predictions in
order to identify all potential enhancers in the human
genome. The lower precision is at least partially
Table 2 Results of the predicted enhancers for experimental validation in the first round of mouse reporter assays
Coordinates (hg19) VISTA ID Enhancer activity Tissues with enhancer activity Reproducibility
Chr2 145339602 145341530 hs1802 Positive Midbrain (mesencephalon) 8/8









Chr8 106602865 106607408 hs1800 Positive Cranial nerve 8/10
Dorsal root ganglion 6/10
Midbrain (mesencephalon) 9/10
Trigeminal V (ganglion, cranial) 8/10
Chr11 118308306 118311240 hs1793 Negative
Chr14 57474144 57478090 hs1791 Positive Midbrain (mesencephalon) 15/15
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Table 3 Results of the predicted enhancers for experimental validation in the second round of mouse reporter assays
Coordinates (hg19) VISTA
ID







Chr1 39,629,409 39,631,707 hs1999 ENH_DISCR_2 Negative
Chr2 7,025,512 7,027,025 hs2015 ENH_DISCR_18 Negative
Chr2 68,419,973 68,421,991 hs2040 Positive Nose 3/5
Chr2 159,885,988 159,889,012 hs2027 Positive Heart 11/11
Chr2 169,971,561 169,974,373 hs2034 ENH_DISCR_37 Negative
Chr3 65,589,981 65,591,565 hs2038 ENH_DISCR_41 Negative
Chr3 72,368,145 72,370,230 hs2006 Negative
Chr3 124,304,700 124,307,917 hs2031 ENH_DISCR_34 Negative
Chr3 141,579,463 141,580,810 hs2041 ENH_DISCR_44 Positive Limb 3/7
Chr4 109,893,210 109,895,294 hs2021 ENH_DISCR_24 Negative
Chr5 176,076,732 176,078,530 hs2007 Positive Heart 3/7
Chr8 59,769,794 59,772,587 hs2029 ENH_DISCR_32 Negative
Chr9 75,758,359 75,760,288 hs2000 Negative
Chr11 74,781,340 74,785,285 hs2047 Negative
Chr12 31,867,650 31,868,817 hs2043 Negative
Chr16 89,384,737 89,387,643 hs2036 Negative
Chr17 45,368,528 45,369,514 hs2033 Positive
Chr17 73,347,819 73,348,933 hs2023 ENH_DISCR_26 Negative
Chr20 48,291,612 48,294,178 hs2045 ENH_DISCR_48 Negative
Chr22 21,953,368 21,954,302 hs2026 ENH_DISCR_29 Positive Tail 9/17
Table 4 Results of the predicted enhancers for experimental validation in the Medaka fish reporter assays
Coordinates (hg19) ID Enhancer activity Tissues with patterns
Chr1 39630305 39631117 + ENH_DISCR_2 Positive Tectum, fin
Chr1 27448948 27449785 - ENH_DISCR_38 Negative
Chr2 64877588 64878573 - ENH_DISCR_16 Negative Not consistent
Chr2 7025939 7026794 + ENH_DISCR_18 Positive Telencephalon
Chr2 169972473 169973432 - ENH_DISCR_37 Positive Epidermis
Chr3 20009087 20009933 + ENH_DISCR_14 Negative Not consistent
Chr3 71276246 71277150 - ENH_DISCR_19 Negative Not consistent
Chr3 124305687 124306362 + ENH_DISCR_34 Positive Epidermis
Chr3 65590259 65591167 - ENH_DISCR_41 Positive Blood_heart
Chr3 141579681 141580471 + ENH_DISCR_44 Weak Blood
Chr4 109893826 109894623 - ENH_DISCR_24 Negative Not consistent
Chr6 158653651 158654413 + ENH_DISCR_1 Negative Not consistent/heart
Chr8 91239118 91239934 - ENH_DISCR_17 Positive Telencephalon
Chr8 59770666 59771377 - ENH_DISCR_32 Positive Telencephalon
Chr10 97054745 97055495 - ENH_DISCR_47 Positive Epidermis
Chr12 95567438 95568125 - ENH_DISCR_35 Positive Blood, ear
Chr12 755392 756170 - ENH_DISCR_45 Weak Epidermis
Chr14 35805596 35806453 + ENH_DISCR_21 Positive Epidermis, late
Chr15 89638466 89639233 + ENH_DISCR_12 Negative
Chr17 46503536 46504314 - ENH_DISCR_13 Positive Telencephalon
Chr17 34953545 34954303 + ENH_DISCR_22 Weak Epidermis, blood
Chr17 73347806 73348761 - ENH_DISCR_26 Negative Not consistent
Chr17 76254538 76255291 + ENH_DISCR_31 Weak Blood
Chr19 33162656 33163445 - ENH_DISCR_40 Positive Blood
Chr20 48293080 48293844 - ENH_DISCR_48 Positive Epidermis, blood
Chr22 28430853 28431678 - ENH_DISCR_25 Positive Tectum
Chr22 21953421 21954149 + ENH_DISCR_29 Positive Telencephalon
Yip et al. Genome Biology 2012, 13:R48
http://genomebiology.com/2012/13/9/R48
Page 12 of 22
compensated for by a higher recall rate. Furthermore, in
the first round of predictions we optimized our method
for a particular assay, while in the second round we
adopted a more general procedure. Some of our pre-
dicted enhancers in the second round may only be
bound by TRFs that are not expressed at the particular
stages of the tested animals. Indeed, the diversity of tis-
sues in which some of our predictions were shown to be
positive suggests that they were targeted by a heteroge-
neous set of TRFs.
In summary, in the two rounds of validation experi-
ments, 42 unique regions were tested and 28 of them
(67%) showed enhancer activities in at least one assay.
Identification of potential long-range TRF regulation
through DRMs
As a next step to identifying distal regulatory elements
with functional roles, we studied potential target genes
of the identified DRMs, and the TRFs that regulate
these genes through the DRMs. A method for associat-
ing potential target genes and predicted enhancers iden-
tified by a genome segmentation approach has been
recently proposed [63]. The main idea was to look for
pairs of predicted enhancers and genes where the signals
of some histone modifications characteristic for enhan-
cers (such as H3K4me1 and H3K27ac) at the enhancer
could predict the expression level of the gene in the
same pair across multiple cell lines. We used a similar
approach to associate our DRMs with potential target
transcripts (Materials and methods; Figure S10 in Addi-
tional file 2). However, instead of manually picking his-
tone modifications known to be related to a particular
type of DRMs, we correlated all types of histone modifi-
cations in our dataset with expression of transcripts in
an exhaustive manner, so that previously unknown func-
tions of histone modifications at DRM sites may also be
discovered. To minimize false positives, we used a strin-
gent correlation threshold after correcting for multiple
hypothesis testing. Subsequently, for each identified
DRM-target transcript pair, we associated TRFs that
may be involved in the long-range regulation by looking
for TRFs with a binding peak at the DRM in a cell line
where there was a strong signal of the histone modifica-
tion used in correlating the pair. We also used these
TRF-potential target gene pairs to form a distal regula-
tory network and performed some additional analyses in
a separate study [31].
For this set of analyses, we also used other ENCODE
cell lines with both histone modification and expression
data in our dataset in addition to the five focused on in
this paper in order to increase statistical power (Materi-
als and methods).
From the different types of histone modification and
gene expression experiments, we identified between 8
and 3,270 pairs of potential DRM-target transcripts. The
distance distributions between DRMs and target tran-
scripts show some interesting patterns (Figure 6a). For
expression values measured by Poly A+ (Poly A
enriched) RNA-seq or Poly A+ CAGE, many of which
are expected to be mRNAs of protein-coding genes,
DRMs as far away as 1 Mbp from the potential target
transcript are as common as those only about 100 kbp
apart. In contrast, for transcripts measured by Poly A-
(Poly A depleted) RNA-seq, more of which are expected
to be non-coding RNAs, the frequency of DRM-target
transcript pairs decreases as the distance between them
increases. For small RNAs, the number of DRM-target
transcript pairs is much lower than for long RNAs, but
this is mainly due to a smaller number of available data-
sets for small RNAs so that fewer transcripts survive the
filtering conditions (Materials and methods).
While some of the identified pairs may be false posi-
tives, there is no apparent systematic bias in our proce-
dure that may cause the observed difference between
the Poly A+ and Poly A- cases. We propose that the dif-
ference could be related to the number of transcripts
each DRM regulates. We observed that, in general, each
DRM regulates a larger number of Poly A+ transcripts
than Poly A- transcripts (Figure 6b). For example, on
average, each DRM regulates 2.5 transcripts according
to Poly A+ CAGE, but only 1.8 and 1.5 transcripts
according to short RNA-seq and Poly A- RNA-seq,
respectively. Some of these cases are caused by single
DRMs regulating multiple transcripts of the same gene,
due to protein-coding genes with many isoforms. In
some other cases, the difference is due to the regulation
of more genes by one DRM. As the distance between
different genes is, on average, larger than the distance
between different transcripts of the same gene, it is the
latter case that helps explain the longer distance
between DRMs and their potential target genes for Poly
A+ transcripts.
This explanation is consistent with a recent finding
that DNA sometimes forms loops through long-range
interactions, to bring multiple anchor genes into close
physical proximity [64]. Such anchor genes were found
to be more active than genes in loops that involve only
two DNA regions in terms of binding signals of RNA
polymerase II.
We also checked the number of DRMs by which each
transcript is regulated. The trends are similar for the
different types of expression experiments (Figure 6c).
About 40 to 50% of transcripts are regulated by only
one DRM, but there is also a significant portion of tran-
scripts regulated by two or more DRMs. As we have
used a very conservative procedure for calling DRM-tar-
get transcript pairs, we believe this is an underestimate
of the actual number of regulating DRMs per transcript.
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Our procedure for associating DRMs and target tran-
scripts could, in principle, detect both statistically signif-
icant positive and negative correlations between the
histone modification signals at the DRM and the
expression level of the target transcript. In reality the
vast majority (almost 100%) of our identified pairs have
a positive correlation. When we examined the actual
types of histone modifications, we found that enhancer-
related marks, including H3K4me1, H3k4me2 and
H3K27ac, are involved in a large fraction of the signifi-
cant correlations (Figure 6d). The active promoter mark
H3K4me3 is also involved in a large fraction of cases,
which may indicate unannotated transcripts (for exam-
ple, non-coding transcripts) or a role of the mark at
some DRMs. We also observed the involvement of the
active chromatin mark H3K9ac in a smaller yet signifi-
cant fraction of the pairs. Indeed, while H3K9ac is most
enriched at PRMs, it also has a clear enrichment at
DRMs compared to the genomic background (Figure S8
in Additional file 2). Finally, the presence of the repres-
sive mark H3K27me3 and active mark H3K36me3,
usually found at gene bodies in a small fraction of our
cases, may be used to estimate the amount of false posi-
tives on our list, although we cannot eliminate the pos-
sibility of their potential roles in gene regulation at
DRMs.
We then examined the TRFs associated with the
DRM-target transcript pairs. We found that DRMs
potentially regulating Poly A+ transcripts have a higher
fraction of EP300 binding than both the set of all DRMs
and the whole genome (except in H1-hESC, which has
too few DRMs to compute the fraction accurately; Table
S4 in Additional file 1). This observation suggests that
the correlation method for associating DRMs and target
transcripts could help identify DRMs that have stronger
activities.
We also studied if there are CTCF binding sites
between our DRMs and potential target transcripts. Tra-
ditionally, CTCF is assumed to play a role in blocking
enhancers [65]. We found that in 97% of our DRM-tar-
get transcript pairs, there is at least one CTCF binding
peak between them, which suggests that CTCF is not
generally blocking long-range interactions for our set of
identified cases. We hypothesize that CTCF blocking
may have a stronger effect for enhancers just a few kilo-
base pairs from TSSs due to space constraints, but for
our DRMs, which are more distal from TSSs, there is a
higher flexibility of the DNA three-dimensional struc-
ture between the DRM and the target transcript so that
CTCF may play a smaller blocking role. In addition, a
recent study of CTCF-mediated chromatin interactions
has suggested that CTCF may actually facilitate the
cross-talk between promoters and regulatory elements
[57], which may also explain some of our cases.
Figure 6 Associating DRMs with potential target transcripts
and TRFs involved. (a) Distance distribution between DRMs and
potential target transcripts for four different types of gene
expression experiments. (b) Distributions of the number of
transcripts that each DRM potentially regulates; 10+ denotes 10 or
more transcripts. (c) Distributions of the number of DRMs that each
transcript is potentially regulated by; 15+ denotes 15 or more DRMs.
(d) Distributions of the number of DRM-target transcript pairs with
which each type of histone modification is involved.
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Motifless binding at HOT regions
In a separate analysis we have found that some ChIP-
seq binding peaks do not have strong DNA sequence
motifs of the corresponding TRFs [20]. They also have
lower binding affinity in general. In the current study
we explored a potential relationship between these
regions and our identified HOT regions.
For each TRF, we examined its binding peaks and
identified those that do not contain any previously
known or newly discovered DNA binding motifs of it
(Materials and methods). We called them motifless
binding peaks of the TRF. We then collected the motif-
less binding peaks of all TRFs for each cell line, and
compared them with our HOT regions.
Using the whole set of binding peaks of all TRFs in
each cell line as background, we found that motifless
binding peaks have very significant overlaps with our
HOT regions (Table 5). This is true no matter whether
we consider all TRF peaks in the whole genome, or only
those in intergenic regions. In all cases, the z-score is
more than 25, which corresponds to a P-value <3 × 10-
138. A substantial portion of binding at HOT regions is
thus attributed to non-sequence-specific binding. In our
separate study, we found that motifless binding peaks
have stronger DNase I hypersensitivity signals [20],
which is also a signature of our HOT regions (Figure 4).
Our analysis also highlights the need for a more com-
prehensive catalog of sequence motifs of DNA binding
proteins. If we instead define a TRF binding peak as
motifless as long as it lacks either a previously known
motif or a newly discovered one - that is, it could still
have a motif from the other source - the overlap of the
resulting ‘motifless’ peaks with our HOT regions
becomes statistically insignificant. Requiring a motifless
binding peak to lack both types of motifs is likely more
reliable.
Discussion
Methods for identifying regulatory modules in silico
There have been a lot of efforts in the past few years to
identify transcriptional regulatory modules computation-
ally [8,9]. The majority of the methods rely on evolu-
tionary conservation and sequence-based features such
as degenerate binding motifs of TRFs. It is now well-
accepted that protein-DNA binding depends not only
on these static features, but also on other dynamic fac-
tors such as chromatin states. Recently, cell-specific
chromatin features have been used to segment the
human genome into different types of regions [63],
which marks an important step forward towards the
identification of cell-specific regulatory modules. In the
current study a lot of protein binding data are used as
examples to learn statistical models for TRF binding
sites, taking even more chromatin features into account.
We hope the six types of regions defined in this study
will serve as a good reference for future studies of regu-
latory modules and for further improving computational
methods for identifying them.
Supervised and semi-supervised prediction of enhancers
Our procedure for identifying enhancers involved the
use of ‘supervised’ machine learning methods - methods
Table 5 Comparisons of motifless binding peaks and our HOT regions





















17,647 (5.02 Mbp) 18,973 (4.67 Mbp) 10,568 (2.07 Mbp) 49.8









18,399 (4.73 Mbp) 11,242 (2.55 Mbp) 6,267 (1.13 Mbp) 25.3









14,822 (4.30 Mbp) 13,872 (3.81 Mbp) 7,023 (1.40 Mbp) 38.2









15,565 (4.50 Mbp) 18,162 (4.54 Mbp) 7,492 (1.52 Mbp) 58.2









12,884 (3.84 Mbp) 18,194 (4.80 Mbp) 8,057 (1.67 Mbp) 53.4
In each cell, the number of regions is given, followed by the total length of DNA covered in parentheses. IR, intergenic regions; WG, whole genome.
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that learn model parameters from known examples.
However, our overall pipeline is not truly supervised in
that we used only supervised models to learn regions
needed by the procedure to identify enhancers, such as
BARs and PRMs. These regions were then used in an
unsupervised manner in the final prediction of enhan-
cers. This design was driven by an insufficient number
of cell-type-specific positive and negative examples of
enhancers. While there are large enhancer catalogs, such
as the VISTA database [6], most of the validation
experiments were done in specific assays (such as
embryos of transgenic mouse) that may not be appropri-
ate as examples for other cell types due to the dynamic
nature of protein binding and gene regulation. In fact,
when we tried to use data from VISTA to learn direct
supervised models for enhancers using chromatin data
from our cell lines as features, the prediction accuracy
was low according to some left-out data not used in
model training. We hope that with the larger-scale vali-
dation efforts of ENCODE [20] and other groups, more
cell-type-specific data will become available and the
construction of highly reliable, supervised predictive
models of enhancers will become possible.
It is also useful to consider semi-supervised methods
[66], which consider data patterns of both regions of
known types and other regions. For instance, one
approach worth investigating is combining the informa-
tion captured by our method and some segmentation
methods [63,67]. As a first step towards this direction,
we have taken the intersection of the predicted enhan-
cers produced by the two approaches, and provide the
files in Additional files 1 and 2.
Accurate association of DRMs and target genes
Our procedure for associating DRMs and potential tar-
get genes is currently constrained by a small number of
cell types for which both histone modification and gene
expression data are available. Simply by chance it is pos-
sible to have a DRM that appears highly correlated with
a gene. It is also difficult to distinguish between direct
regulation and indirect correlations due to co-expressed
genes. As a result, we decided to use a very stringent
procedure based on the Bonferroni correction method
for multiple-hypothesis testing, which is known to be
too conservative. While the procedure gives us some
associations that are of higher confidence than ones
possibly called by a less stringent procedure, one
obvious drawback is an expected high false negative
rate. Our analysis may also be biased, since the DRM-
target transcript pairs that survive the stringent criteria
are likely the most extreme cases. We believe one direct
consequence is the lack of negatively correlated pairs on
our identified list. It appears that positive regulation
events at enhancers result in more extreme positive
correlations than the negative correlations caused by
negative regulation events at DRMs such as silencers.
We expect that a more complete picture of gene regula-
tion through DRMs will be drawn when data from more
cell types become available.
Another promising direction for associating DRMs
with target genes is by using whole-genome DNA long-
range interaction data, either involving a target protein
that mediates the interaction (such as ChIA-PET [28])
or without (such as Hi-C [68]). Currently, there are few
datasets available, and among these, some suffer low
reproducibility [64] and low resolution [68]. Some tech-
nological advancements that lead to better data quality
are already underway [69]. We hope that the study of
long-range gene regulation will be facilitated by large-
scale, high-quality DNA interaction data in the coming
years.
Some possible interpretations of HOT regions and
improvements of the calling procedure
We have found that there are regions bound by many
different TRFs in the same cell line, which we call HOT
regions. As discussed, the observed binding of many
TRFs at a small region may be due to the average of a
cell population. We found that these regions have high
DNase I hypersensitivity in general, as well as high sig-
nals of almost all types of histone modification (Figure
4). The strong signals suggest that they could be regions
with general open and accessible chromatin, where
TRFs can easily bind them even without cognate
sequence motifs.
It has also been shown that the binding of a TRF may
promote steady-state binding of other TRFs, even for
those that share the same DNA response elements [70].
This observation was explained by an ‘assisted loading’
mechanism, where the binding of a TRF increases local
chromatin accessibility, and makes it easier for other
TRFs to bind regions nearby. HOT regions could be
extreme examples of such assisted loading.
To further study HOT regions, it is of utmost impor-
tance to make sure that the co-occurrence of binding of
different TRFs is not due to experimental or computa-
tional artifacts, such as erroneous read mapping (for
example, by mapping all reads of a broad repeat region
to the same copy of the repeats, which would result in
an artificially strong binding signal of the region), or
natural co-binding of TRF co-factors. We have applied a
rigorous procedure to eliminate as many of the issues in
data quality, reproducibility, mapping, and global co-
binding as possible. We have also partially taken into
account the non-uniform nature of TRF binding in the
whole genome, by using a co-occurrence matrix of TRF
binding peaks produced by a method based on Genome
Structure Correction [20,71]. We propose that the
Yip et al. Genome Biology 2012, 13:R48
http://genomebiology.com/2012/13/9/R48
Page 16 of 22
procedure for calling HOT regions can be further
improved by directly applying Genome Structure Cor-
rection in evaluating the statistical significance of bind-
ing profiles, and considering the local context of
different regions. For example, it may be more biologi-
cally interesting to see the binding of many TRFs at an
unannotated intergenic region than at the promoter of a
highly expressed gene. To give a higher HOT score to
the former, the HOT region identification method needs
to evaluate the statistical significance based on a back-
ground distribution specific to the type of regions of
interest. It can be roughly done by calling HOT regions
of different classes of annotated elements (for example,
promoters versus gene bodies versus intergenic regions)
separately. To deal with the large fraction of intergenic
regions in the genome, the functions of which are still
not well understood, the unsupervised segmentation
approach [63,67] provides one systematic way to define
the different element classes at the genome scale.
Identified regions as a resource
We make available our three paired types of regions
from the five cell lines as supplementary files [26], in
standard formats that can be easily loaded into genome
browsers as data tracks. We also provide some addi-
tional files, such as predicted DRM-target transcript
pairs and the TRFs involved. Details of all these files can
be found in Additional files 1 and 2.
Materials and methods
Source of ENCODE data
The raw sequencing data for TRF binding (Table S1 in
Additional file 1), histone modification (Table S2 in
Additional file 1), open chromatin signals and expres-
sion values used in this study can be downloaded from
the UCSC Genome Browser [72]. The complete list of
datasets, their unique identifiers and download paths
can be found in Table S5 in Additional file 1.
Identifying BARs and BIRs
The human reference genome (build hg19) was divided
into 100 bp bins. For each cell line, we collected chro-
matin features from ENCODE and computed the aver-
age signal of each feature across the 100 bp of each bin.
The features include DNase I hypersensitivity, FAIRE,
and histone modifications [20]. Bins that overlap with
the binding peak of a TRF were collected as positive
examples of TRF binding sites. To avoid long running
time of computer programs, 5,000 of these positive bins
were randomly sampled; 5,000 non-positive bins were
randomly sampled from the whole genome as negative
examples. These two sets of examples were used to
train random forest classifiers using Weka [73] as fol-
lows. The examples were divided into ten disjoint
subsets with equal size. A ten-fold cross-validation pro-
cedure was applied, with nine subsets used to train a
classifier and the remaining subset used to test its per-
formance, where each of the ten subsets acted as the
testing set in turn. Each time a BAR score was given for
each bin, and the order of these scores was used to con-
struct the receiver-operator-characteristic (ROC) and
precision-recall (PR) curves. The final accuracy values
were computed as the average areas under the curves of
the ten test sets. Since the negative examples may con-
tain binding peaks of TRFs not included in the dataset
and binding sites of the included TRFs that are not
strong enough to be called as peaks, the reported accu-
racy values are only rough estimates of the ability of the
learned models to identify binding active regions. The
final list of BARs was composed of bins with an average
BAR score from the ten folds larger than 0.9. Bins with
an average BAR score <0.1 and not overlapping binding
peaks of any TRFs in the dataset were collected to form
the list of BIRs.
Identifying PRMs and DRMs
A machine-learning procedure similar to the one for
identifying BARs was applied to identify PRMs. The
same datasets were used as features of 100 bp bins. In
this case, the positive set was composed of bins at the
TSSs of expressed genes, defined as genes with at least
one read per kilobase per million mapped reads
(RPKM) [29] in an RNA-seq experiment or at least 1
read per million mapped reads (RPM) in a CAGE or
diTag experiment conducted for the cell line. The nega-
tive examples were composed of random bins from
three different sets: 1) bins not overlapping with TRF
binding bins in the whole genome; 2) non-POL2RA
TRF binding peaks at least 10,000 bp away from any
coding and non-coding gene annotated in Gencode ver-
sion 7 level 1 and level 2; and 3) bins not overlapping
with TRF binding peaks between 1,000 and 5,000 bp
upstream or between 200 and 1,000 bp downstream of
a TSS. The three subsets ensure that the negative set
contains bins that are non-TRF binding, TRF binding
but not close to annotated genes, and promoter-proxi-
mal but with a lower chance of TRF biding. The third
subset was specifically included so that the resulting
models do not simply use open chromatin as the single
most important feature to identify PRMs. For each cell
line, a model was trained to give a PRM score for each
bin. The average PRM score with exactly 1% negative
examples higher than it was used as the threshold. The
final list of PRMs consists of bins with an average PRM
score higher than the threshold. The DRM bins were
then defined as non-PRM BAR bins at least 10 kbp
from any Gencode version 7 level 1 and level 2 coding
and non-coding genes.
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Identifying HOT and LOT regions
For each cell line, we grouped different experiments for
the same TRF together and computed the average bind-
ing signal for each 100 bp bin. The values were then
discretized into five values: top, second, and third 25
percentiles, fourth 25th percentile that are not zeros,
and zeros. The extra group for zeros was to handle the
large number of zeros in a typical ChIP-seq experiment
for TRF binding. For each bin, we then computed a
degree of region-specific co-occurrence, which is a
weighted sum of the discretized values of the bin from
the different TRFs. The weight of each TRF was com-
puted as follows. First, we took the global co-occurrence
z-score matrix of TRF binding peaks computed by using
Genome Structure Correction [20,71]. A raw score of
each TRF was computed as the average z-score with all
other TRFs in the matrix. The raw score was then nor-
malized linearly so that the TRF with the lowest score
received a weight of 1 and the TRF with the highest
score received a weight of 1/n, where n is the total
number of TRFs with ChIP-seq data from the cell line.
This weighting scheme de-emphasizes TRFs that are
globally co-associating with other TRFs in the counting
of region-specific co-occurrence of binding. The HOT
and LOT regions were then defined as the bins with the
top 1% degrees of region-specific co-occurrence and the
bins with the bottom 1% non-zero degrees of region-
specific co-occurrence, respectively.
Constructing box-and-whisker plots for open chromatin,
histone modification and TRF binding signals
For each 100 bp bin within a type of regions and each
open chromatin, histone modification or TRF binding
dataset, we computed the average signal value of the
dataset within the 100 bp bin. We represent the result-
ing distributions by box-and-whisker plots. To prevent
extreme outliers from dominating the scales of the
plots, we excluded outliers smaller than Q1 - 5 IQR and
those larger than Q3 + 5 IQR, where Q1 is the bottom
25th percentile, Q3 is the top 25th percentile, and IQR
is the inter-quartile range, defined as Q3 - Q1.
First round identification and validation of potential
enhancers in mouse embryos
We combined the ENCODE chromatin data available
for GM12878 and K562 as of January 2010 to predict
binding active regions using a pipeline similar to the
one for the BARs in Figure 1. We removed bins within
2 kbp upstream or 500 bp downstream of Gencode
TSSs, and bins within 1 kbp from Gencode and Refseq
exons. We then downloaded the phyloP conservation
scores [74] of the resulting bins from the UCSC Gen-
ome Browser [72] based on multiple sequence align-
ments of 44 vertebrate genomes, and took the top 2% of
the bins with the highest scores, corresponding to a cut-
off score of 1.2. We merged adjacent bins into longer
regions, and kept only those merged regions with a size
between 0.8 and 4 kbp. After that, for each merged
region we counted the number of binding motifs of a
set of TRFs known to be highly expressed in mouse
embryos based on a gene expression atlas [75]. The
genes include members of the OCT and SOX families
among others. The motifs of these genes were taken
from Transfac [62]. The top 50 predictions with the
highest binding motif density were then used as candi-
dates of potential enhancers.
The predictions were originally made according to
human reference genome build hg18. We used the Lift-
Over tool [76] at the UCSC genome browser to convert
the coordinates into human reference genome build
hg19.
The enhancers were tested in embryos of transgenic
mice on day E11.5 with a lacZ reporter gene fused with
an hsp68 promoter as previously described [61].
Second round, whole-genome identification and
validation of potential enhancers in mouse and Medaka
fish embryos
We developed two methods to identify potential enhan-
cers in the whole human genome, and took the intersec-
tion of their predictions to form our candidate set for
experimental validation. We used data from K562, as
the initial plan was to test the enhancers in vitro in
K562 cells.
The first method is a variation of the method for the
first round of enhancer prediction. We took the BARs
and removed from them all bins either with a promoter
score >0.8, within 2 kbp from a Gencode version 3c
TSS, intersecting with a Gencode exon, or with a phast-
Cons primate score <0.1 downloaded from the UCSC
Genome Browser. We then merged adjacent bins in the
resulting set into longer regions, and removed regions
with no binding motifs of TRFs expressed in K562. The
final list contains 55,857 regions.
The second method used a two-stage method to learn
locations of TRF binding sites from chromatin, conser-
vation, sequence and gene annotation features. In the
first stage, large windows of 1 kbp were made and fea-
ture values were aggregated to learn statistical models
for distinguishing TRF binding peaks from random loca-
tions. In the second stage, the shapes of TRF binding
signals around binding peaks were used to construct
features for learning models that distinguish binding
peaks from flanking regions. From the resulting list of
regions predicted to have active TRF binding, repeats
were removed and the high-scoring ones were kept. The
list was then further filtered by removing regions that
overlap Gencode version 3c exons or within 2 kbp from
Yip et al. Genome Biology 2012, 13:R48
http://genomebiology.com/2012/13/9/R48
Page 18 of 22
a Gencode TSS. Finally, we considered only candidate
regions that involve H3K4me1 or H3k4me3 in their pre-
diction process. The resulting list contains 56,256
regions.
We then combined the two lists by taking their inter-
section, and refined the boundaries of each region so
that each has a minimum length of 100 bp and a maxi-
mum length of 700 bp. We further considered the high-
confidence ones with median H3K4me1 or H3K4me3
signals >5. The final list contains 13,539 sequences of
potential enhancers.
The mouse assay was performed in same way as in the
first round of validation. The Medaka fish assay was
performed over the first three days of development, as
described [20].
Associating DRMs with target transcripts and the TRFs
involved
We took the union of the DRM bins identified from the
five cell lines to form a comprehensive set of non cell-
line-specific potential DRM bins. We merged adjacent
bins into modules, allowing 100 bp gaps between any
two DRM bins, resulting in 129,326 modules (Figure
S10A in Additional file 2). We then took all Gencode
version 7 level 1 and level 2 transcripts, and filtered out
those with <2 RPM/RPKM in all cell lines with expres-
sion data of the transcript or less than two-fold expres-
sion level difference among the cell lines. The resulting
set contains 64,075 transcripts.
We considered four types of gene expression experi-
ments in whole cells: Poly A+ RNA-seq, Poly A- RNA-
seq, RNA-seq of short RNAs, and Poly A+ CAGE (Fig-
ure S10B in Additional file 2). For each DRM, we con-
sidered only histone modifications with at least a signal
value of 2 in one or more cell lines, and at least a two-
fold signal difference among the cell lines. For the
DRMs and transcripts that pass the above selection cri-
teria, we considered only pairs with at least seven
matching cell lines for both histone modification and
gene expression data, and are on the same chromosome
no more than 1 Mbp apart, where this distance thresh-
old was based on a recent finding that there are few
long-range DNA interactions that span more than 1
Mbp for a TRF according to some ChIA-PET experi-
ments [64]. Finally, we computed Pearson correlations
for these pairs, and kept the ones with a Bonferroni-cor-
rected P-value <0.01 based on Fisher’s transformation.
Depending on the type of histone modifications and
RNA experiments, 8 to 3,270 DRM-target transcript
pairs were identified (Figure S10B in Additional file 2).
We next associated TRFs with each DRM-target tran-
script pair by considering TRFs with a binding peak at
the DRM in a cell line with a signal value of 2 or more
for the histone modification involved, which resulted in
4 to 2,129 potential TRF-target transcript pairs con-
nected by the DRMs.
Defining motifless binding peaks and comparing them
with HOT regions
For each cell line and each TRF with ChIP-seq experi-
ments in the cell line, we collected the binding peaks of
the TRF, and identified the ones that do not contain a
binding sequence motif of it. This requires that the
binding peak contains neither a previously known motif
nor a motif newly discovered from ENCODE data.
These two lists of motifs and their occurrences in the
human genome were produced by a separate pipeline
[77]. For each cell line, we then collected all these
regions to form the set of motifless binding peaks for
the cell line. In this procedure, a region is defined as a
motifless binding peak as long as one TRF has a binding
peak there without a corresponding sequence motif, but
the region is allowed to contain sequence motifs of
other TRFs.
We then intersected the motifless binding peaks with
our HOT regions. Since our HOT regions were identi-
fied from the whole human genome but the motifless
binding peaks were all from ChIP-seq binding peaks, we
first identified the subset of HOT regions within these
peaks. We then determined their intersection with the
motifless binding peaks, and evaluated the statistical sig-
nificance of the intersection by block sampling [71],
using the whole set of binding peaks as the domain. For
each cell line, we took 100,000 random block samples
and computed the intersection in each of them in terms
of base overlap ratios. The resulting distribution of
intersection values is expected to follow a Gaussian dis-
tribution, and we used the fitted Gaussian to compute a
z-score of our observed intersection value for each cell
line. We also repeated the whole procedure for only the
intergenic regions, defined as regions at least 10,000 bp
from any Gencode version 7 level 1 and level 2 genes.
Additional material
Additional file 1: Supplementary materials. This file contains
supplementary tables, legends of supplementary figures, and information
about a supplementary web site.
Additional file 2: Supplementary figures. This file contains
supplementary figures.
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